15 June 2023 | Thursday | News
Bristol Myers Squibb (NYSE: BMY) announced that its Board of Directors has declared a quarterly dividend of fifty-seven cents ($0.57) per share on the $0.10 par value common stock of the company. The dividend is payable on August 1, 2023, to stockholders of record at the close of business on July 7, 2023.
In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on September 1, 2023, to stockholders of record at the close of business on August 1, 2023.
© 2025 Biopharma Boardroom. All Rights Reserved.